IPITT demonstrated that TG treatment dramatically and dose-dependently alleviated the severe insulin insensitivity occurring in STZ-induced T2DM mice, indicating the improvement of insulin sensitivity upon TG treatment (Fig. 4D). Here, INS is linked to type 2 diabetes mellitus.